Latest Administration News

AVITA Medical reported a 21% revenue increase in Q2 2025 driven by expanded sales and new product launches, yet continues to face net losses and liquidity challenges requiring loan covenant waivers.

AVITA Medical’s Q2 2025 update reveals a temporary setback in RECELL demand due to Medicare reimbursement delays, offset by strong revenue growth and promising clinical data. The company anticipates recovery and renewed growth in the second half of the year.

AVITA Medical reported a 21% increase in Q2 commercial revenue to $18.4 million and narrowed its net loss, yet faces a reimbursement hurdle that forced a downward revision of full-year guidance. The company highlights clinical progress and strategic board appointments as it navigates payment challenges.

Novo Resources Corp. reported key drilling milestones at its Pilbara and New South Wales projects in Q2 2025, alongside a reduced net loss and ongoing liquidity challenges. The company’s exploration momentum continues despite material uncertainty over its going concern status.

Celsius Resources reports steady progress on the MCB Copper-Gold Project feasibility and engineering design, while engaging multiple parties in financing discussions including a new memorandum of understanding with Kiri Industries.

Duxton Farms reported a significant $12.5 million net loss for FY2025, reversing last year’s profit, while declaring an 85% franked dividend of 24 cents per share. The company’s revenue dipped due to property sales and increased expenses tied to a proposed acquisition.

Trigg Minerals has acquired 100% of the Tennessee Mountain Tungsten Project in Nevada, marking a strategic expansion into critical minerals with a historically significant tungsten resource. The move aligns with rising tungsten demand and the company's goal to become a key supplier of defence metals.

AMP reported a 9.2% increase in underlying net profit after tax to $131 million for the first half of 2025, driven by robust cashflow growth and steady performances across its wealth and banking divisions. The company also declared a 2.0 cents per share interim dividend, maintaining disciplined cost control amid ongoing strategic investments.

Toys"R"Us ANZ has formalised a Deed of Company Arrangement, paving the way for Directed Electronics Australia to acquire the company and trigger its delisting from the ASX.

Finexia Financial Group has ended talks on a major disposal deal and is managing loan defaults with fresh collateral, while expanding its childcare lending strategy.

Nyrada’s Phase I clinical trial for Xolatryp™ concludes with positive safety and pharmacokinetic results, paving the way for a Phase IIa study in acute myocardial infarction patients.

Nanosonics has secured FDA clearance for its next-generation trophon3 device and trophon2 Plus software upgrade, setting the stage for significant growth in the US medical disinfection market.